
CerraCap Ventures

A strategic investment firm backing therapies for diseases with high unmet medical need

Brace Pharma Capital is an investment firm set up by EMS S/A, described as the largest pharmaceutical company in Brazil, together with high net worth biotech investors. It backs therapies aimed at diseases with a high degree of unmet medical need and limited existing treatment options, framing the therapies it targets as life changing for patients rather than incremental improvements on what already exists. The firm invites companies seeking investment to make contact directly through its site, presenting the process as open to candidate investment companies working in this area. It also presents its team and board on a separate page for those wanting to learn more about who runs the firm and how it is structured as a partnership between its two types of backers.
Profile written by TrustList from the business's own published information, Sep 2026.
2 images — click to enlarge
Used it? Your experience helps other buyers decide.
Write a reviewNo questions yet. Be the first to ask about Brace Pharma Capital.
Similar listings buyers compare against this one.

CerraCap Ventures

Chicago-based accelerator for technology companies serving the real estate industry

Company studio and early-stage investor that designs, builds and funds startups with hands-on founder support

Venture investor backing entrepreneurs building companies out of India

Corporate venture arm of Singtel Group helping start-ups grow beyond their home markets

Global trading and investment firm providing market liquidity and quantitative research
Everything here links back to the same verified catalogue. Pick your next stop.